Harmine is a member of a class of drugs called DYRK1A inhibitors. In 2019 and 2020, the researchers reported that DYRK1A inhibitors can synergize with TGF-beta signaling as well as GLP-1 receptor ...
Knowing that TGF-Beta was capable of unlocking its receptor while bound by LAP, the UCSF scientists suspected that these proteins might have many more states than just two, which—using typical ...
Transforming Growth Factor Beta (TGF-β) is a key immune-suppressive factor ... while we prepare for an Investigational New Drug Application (IND) submission to FDA for IO170.” ...